Vascular Grafts Market

Vascular Grafts Market Outlook (2022-2026)

Global sales of vascular grafts are anticipated to rise at a CAGR of 6.5% from 2022 to 2026. At present, the global vascular grafts market is valued at US$ 3.5 billion and is expected to reach a valuation of US$ 4.5 billion by 2026.

Demand for endovascular aneurysm repair treatment is expected to rise at 6% CAGR over the forecast period. Increasing need for less invasive procedures and rising popularity of stent grafts to treat atherosclerosis are major factors driving the demand for endovascular aneurysm repair surgery procedures.

Report Attributes	Details
Vascular Grafts Market Size (2022)	US$ 3.5 Billion
Projected Market Value (2026)	US$ 4.5 Billion
Global Market Growth Rate (2022-2026)	6.5% CAGR
Market Share of Endovascular Aneurysm Repair Treatment	50%
Key Companies Profiled	Endologix Inc. OrbusNeich Cook Medical Cryolife Getinge Group LeMaitre Vascular Inc Medtronic PLC Terumo Medical Corporation W.L. Gore & Associates Inc. Vascular Graft Solution Ltd.

Demand Analysis of Vascular Grafts (2017-2021) Vs Market Outlook (2022-2026)

“Rising Prevalence of Cardiovascular Diseases Driving Need for Vascular Grafts”

According to Fact.MR, a market research and competitive intelligence provider, demand for vascular grafts is expected to increase at a CAGR of 6.5% from 2022 to 2026.

Rising prevalence of chronic renal diseases, aortic aneurysms, and rising cardiovascular illnesses are expected to drive market expansion. Excessive alcohol consumption, bad eating habits, and adopting a sedentary lifestyle are all contributing factors to the rising prevalence of heart problems.

Vascular grafts are applied to bypass unhealthy or diseased blood vessels. These grafts are necessary to repair damaged arteries, veins, and blood vessels as well as to replace rigid blood vessels. These grafts may be artificial, partially artificial, or derived from the body of the patient.

Other factors that are anticipated to boost market revenue growth over the forecast period, include a rising focus on early diagnosis of diseases and disorders and growing awareness of the advantages of cardiovascular grafts. Additionally, a rise in the number of surgical procedures, research projects, and requests for less invasive procedures that hasten recovery are the factors fueling market expansion.

What is a Key Trend Boosting the Sales of Vascular Grafts?

“Increasing Demand for Next-generation Tissue-engineered Vascular Grafts for Treatment of Several Chronic Diseases”

The growing need for hemodialysis boosts the demand for vascular graft products and propels the hemodialysis vascular grafts market expansion. Dialysis procedures will increase globally due to an increase in end-stage renal illnesses and a growing patient population with chronic kidney disease. Additionally, for a successful hemodialysis procedure, patients need an arteriovenous graft that functions well.

Next-generation tissue-engineered vascular grafts are being created as a result of technological advances to treat various vasculopathies. With this method, major problems, including intimal hyperplasia, thrombosis, and beneficial graft remodeling are properly addressed.

The use of minimally-invasive direct coronary artery bypass treatment has also increased due to the rising demand for minimally invasive procedures and their safety and low mortality rate. Additionally, it is compatible with cardiopulmonary bypass and aortic cross-clamp. The development of surgical methods utilizing coronary stent grafts would drive the demand for vascular grafts.

Demand for vascular grafts is anticipated to increase significantly during the projected period as a result of advancements in new technologies for the production of novel goods and increased demand for vascular procedures.

Which Factors are Limiting Vascular Grafts Market Expansion?

“Lack of Qualified Professionals & High Cost of Vascular Grafts”

The market is being hampered by a lack of highly qualified employees for conducting vascular bypass surgeries and by the unavailability of attractive reimbursement policies in developing countries. Some of the challenges limiting the market growth are the high cost of treatments and difficulties in prosthetics and other grafts.

If a vascular transplant fails, substantial negative effects on consumer health may result. Vascular graft malfunction puts consumers' lives in danger, which will seriously impede their adoption of cutting-edge technology and might restrict the market growth throughout the forecast period.

Failure of a vascular graft also increases the expense of the treatment because it must be repeated. These factors collectively have shown to be significant barriers to the growth of the market for vascular grafts.

What are the Key Opportunities for Aspiring Market Players?

“New Companies Focusing on Production of Efficient Vascular Grafts”

Emerging market players are focused on product enhancements. New companies are concentrating on the creation and marketing of innovative technologies to increase the efficacy of vascular grafts.

• VasoBio, a biotech start-up based in the U.S., is striving to functionalize vascular grafts by using advanced coating technology that will make them resistant to thrombosis, infection, and blood coagulation.

Which Region is Expected to Generate High Revenue for Vascular Graft Manufacturers?

“Continuous R&D Efforts for Creation of Grafts Using Biomaterial in North America”

North America dominates the vascular grafts market. The market expansion in North America is being driven by an increase in the prevalence of chronic diseases, and attractive reimbursement policies.

The market is growing as a result of increased investments in R&D, a rise in vascular operations, rising health awareness, wide availability of cardiovascular treatment facilities, and the adoption of innovative vascular graft solutions.

Rising demand for vascular composite allografts & hemashield grafts and continuous R&D efforts for the creation of grafts using biomaterial are the elements driving the market growth in North America.

Country-wise Insights

How is the Market for Vascular Grafts Evolving in the U.S.?

“Increase in Minimally-Invasive Heart Valve Surgeries in the U.S.”

The U.S. vascular grafts market is expanding due to factors such as an ageing population, growing usage of small diameter vascular grafts, an increase in cardiovascular disorders, the production of significant quantities of vascular grafts, and an advanced healthcare system.

One of the most common surgical procedures, coronary artery bypass grafting (CABG) surgery sees about 500,000 operations annually in the U.S. The expansion of the market in the United States is being driven by an increase in the demand for synthetic vascular grafts, increased research & development in tissue-engineered products, and a rise in minimally invasive heart valve surgeries.

The market expansion is also being fueled by significant advancements in the creation and use of minimally invasive procedures for cardiac surgeries. The high prevalence of aortic aneurysms and atherosclerosis will increase demand for vascular bypass surgery, driving up industry value during the projection period.

Why is the Market for Vascular Grafts Prominent in China?

“Rising Penetration of Innovative Medical Technologies in China”

The market in China is projected to rise at a CAGR of 8% over the forecast period. Increased prevalence of end-stage kidney diseases is anticipated to propel market expansion. Additionally, the market in China is projected to expand due to cardiac problems that cause premature deaths.

The vascular grafts market in China is expanding due to the rising use of vascular fibular and bone grafts, rising penetration of innovative medical technologies, government support & initiatives to raise public awareness about various chronic conditions, and the emergence of advanced diagnosis and detection systems.

Category-wise Insights

Which Treatment Type Will Majorly Contribute to Market Revenue Growth?

“Endovascular Aneurysm Repair (EVAR) Treatment Highly Preferred Due to Cost-effectiveness”

Based on treatment, the vascular grafts market is divided into endovascular aneurysm repair (EVAR), peripheral vascular repair, and hemodialysis access. Endovascular aneurysm repair (EVAR) treatments account for over 50% share of the global market.

Compared to open surgery, endovascular aneurysm repair provides patients with abdominal aortic aneurysms with more affordable care. Additionally, the use of endovascular aneurysm repair surgery procedures will increase due to problems associated with open repair operations.

A fabric tube known as an endovascular stent graft is held in place by a metal mesh structure called a stent. Although it can be used for several blood vessel issues, it is most frequently employed to strengthen an aneurysm, a weak area in an artery.

The need for endovascular stents is anticipated to increase as EVAR replaces traditional open thoracic aorta procedures and endovascular technology advances. Endovascular grafts also hasten to heal and lessen pain compared to open chest surgeries. It also results in shorter hospital stays, broadening its appeal.

The market expansion is primarily being driven by the increasing use of endovascular surgery to treat aneurysms, the preference for minimally-invasive surgery over open surgery, and the ageing global population.

Which End User Will Emerge as Key Market Contributor?

“Wide Availability of Advanced Treatments Makes Hospitals Most Attractive”

On the basis of the end user, the market is segmented into hospitals and ambulatory surgical centers. Hospitals are projected to represent a significant share of the global vascular grafts market during the assessment period. Vascular grafts are typically used at hospitals since these facilities are eligible for government funding to cover the high cost of the equipment and services needed during an operation.

Due to heart examinations are frequently conducted in hospitals, medical technology and healthcare corporations are prioritizing these facilities as their top distribution locations for vascular grafts.

The most popular option and ideal location for vascular access operations, from dialysis to cardiovascular, are hospitals. The demand for vascular grafts in hospitals will be fueled by a wide range of possible treatments and the use of innovative technology that reduces post-operative problems.

Competitive Landscape

Top companies in the vascular grafts market are rapidly making investments in cutting-edge technology to create novel vascular grafts, including customized vascular grafts. By increasing the product mix through acquisitions and joint ventures, market participants focus on their current product portfolio.

For instance :

• In 2021, for Zenith’s fenestrated endovascular graft, Cook Medical obtained FDA breakthrough device designation. For fatal or permanently crippling diseases or disorders, the product offers more efficient diagnosis or treatment.

Key Segments in Vascular Grafts Industry Research

• By Treatment :

  • Endovascular Aneurysm Repair (EVAR)
  • Peripheral Vascular Repair
  • Hemodialysis Access

• By Raw Material :

  • Polyester
  • ePTFE
  • Polyurethane
  • Biosynthetic

• By End User :

  • Hospitals
  • Ambulatory Surgical Centers

• By Region :

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa